Home > List All Publishers > PharmaLive Special Reports

PharmaLive Special Reports

Canon Communications LLC is a leading publisher, trade show producer, and digital media and data company for the pharmaceutical, medical manufacturing, general design, microelectronics, and packaging industries. Canon leverages the expertise, knowledge, and data acquired in the process of producing leading trade information resources to produce in-depth special reports for the purposes of market research, industry research, business analysis, competitive intelligence, and business development.

Canon Communications produces an extensive collection of print publications, trade shows, and digital resources including: Med Ad News, R&D Directions, Medical Device & Diagnostic Industry, IVD Technology, Medical Device Technology, MX, Pharmaceutical and Medical Packaging News, Appliance Magazine, PharmaLive.com, DeviceLink.com, MDRWeb.com, eKnowledgeBase, and more.

List of reports from PharmaLive Special Reports

Account Rosters: Health-Care Advertising Agencies & Their Rosters 2006 5/1/2006 \| published by: PharmaLive Special Reports ... agencies regarding the product and corporate advertising accounts that they promote. This annual report provides information on thousands of accounts from more than 400 pharmaceutical, biotechnology, diagnostic, device and other companies serviced by the healthcare ... \| more...	$445.00
Top 500 Prescription Medicines by Worldwide Sales - 2006 6/1/2006 \| published by: PharmaLive Special Reports ... prescription medicines that pharmaceutical, biotechnology, and specialty companies manufacture and sell. The information in this report is supplied by the companies. This document provides information on 500 product sales entries representing more than 75 companies. ... \| more...	$445.00
Top 50 Pharmaceutical Companies and Their Pipelines for 2006 9/1/2006 \| published by: PharmaLive Special Reports ... special report provide the following for each product: chemical or substance composition, intended indication, clinical status, region of development, and developer/marketer. All phases of development, concentrating on products in development in the United States, Europe, ... \| more...	$445.00
Top 15 Therapeutic Categories 2006 10/1/2006 \| published by: PharmaLive Special Reports ... awaiting approval and clinical trials status in the United States. Each unique product is detailed - including the phase it is in, the primary disease it treats, and the developer/partner developer of the respective drug. \| more...	$445.00
Top 15 Japanese Pharmaceutical Company Pipelines 2006 10/1/2006 \| published by: PharmaLive Special Reports ... each product: chemical or substance composition, intended indication, clinical status, region of development, and developer/marketer. All phases of development, concentrating on products in development in Japan, Europe, and the United States, have been considered for ... \| more...	$295.00
Top 50 Companies That Specialize 12/1/2006 \| published by: PharmaLive Special Reports ... 50 specialty companies that are publicly traded and report their financial information. The rankings of each specialty company include total revenue, net income, earnings, location, website and the main area of concentration for the business. \| more...	$195.00
Drug Approvals Over Time 2007 2/7/2007 \| published by: PharmaLive Special Reports ... drug application or biologics license application. These medicines include new molecular entities, biotechnology drugs, biologicals, imaging agents, branded generics, and branded formulations of existing products. Excluded from this list are nonbranded generics approved via an ... \| more...	$195.00
From Pipeline to Market 2007 6/1/2007 \| published by: PharmaLive Special Reports ... drugs are separated into sections by their approved or development status. Each section provides the product's commercial name or product code, chemical or substance composition, the approved or intended application, and developer with company website. \| more...	$445.00
Top 50 Companies That Specialize 2008 1/1/2008 \| published by: PharmaLive Special Reports ... 50 specialty companies that are publicly traded and report their financial information for 2007, 2006, and 2005. The rankings of each specialty company include total revenue, net income, earnings per share, location, Website and the ... \| more...	$95.00
Drug Approvals Over Time 2008 3/1/2008 \| published by: PharmaLive Special Reports ... prescription products cleared for marketing for the first time by FDA since 1990. Additionally, this special report chronicles the current marketer of each product or if the medicine has been withdrawn from the U.S. marketplace. \| more...	$145.00
Account Rosters: Healthcare Marketing Communication Agencies 2008 4/1/2008 \| published by: PharmaLive Special Reports ... edition, provides information on thousands of accounts from more than 600 pharmaceutical, biotechnology, diagnostic, device and other companies serviced by the healthcare communications agencies. New this year, we’ve included financial information and agency profiles. The ... \| more...	$495.00
Combination - The Top 50 Pharmaceutical and Biotechnology Companies with Their Pipelines 5/1/2008 \| published by: PharmaLive Special Reports ... based on their health-care revenue. Each of these special reports features the pipelines presented by company in alphabetical order. The pipelines in these special reports provide the following for each product: chemical or substance composition, ... \| more...	$673.00
Drugs in Development: From Pipeline to Approval 6/1/2008 \| published by: PharmaLive Special Reports ... entities, indications and formulations. The drugs are separated into sections by their approved or development status. Each section provides the product’s commercial name or product code, chemical or substance composition, the approved or intended application, ... \| more...	$445.00
Top 50 Pharmaceutical Companies & Their Pipelines 2008 9/10/2008 \| published by: PharmaLive Special Reports ... The following information is included for each product listed in their pipelines: Chemical or substance composition, Intended Indication, Clinical Status (Preclinical, Phase I, II, III, Awaiting Approval), Region of Development (United States, Europe, Japan), and ... \| more...	$465.00
Top 15 Japanese Companies & Their Pipelines 2008 10/8/2008 \| published by: PharmaLive Special Reports ... for each product: chemical or substance composition, intended indication, pipeline status, region of development, and developer/marketer. All phases of clinical development have been considered for this special report — preclinical, Phase I, Phase II, Phase ... \| more...	$275.00
Top 50 Specialty Companies 10/27/2008 \| published by: PharmaLive Special Reports ... by 2007 revenue. The charts for the specialty companies encompass total revenue, net income and earnings per share for 2005, 2006 and 2007 as well as headquarters location, Website and the main areas of business ... \| more...	$150.00
Top 15 Therapeutic Groups 11/12/2008 \| published by: PharmaLive Special Reports ... in clinical trials and those awaiting approval in the United States.Data is presented in easy-to-read chart format with each therapeutic category detailed by, Product name, Phase of development / Status, Disease/medical use, Therapeutic category and ... \| more...	$425.00
Drugs in Development: From Pipeline to Market 6/18/2009 \| published by: PharmaLive Special Reports ... development and on the market in the United States, including new chemical entities, indications, and formulations approved from June 2008 to April 2009. Drugs are organized by their approved or development status. Each section provides: ... \| more...	$485.00
Cardiovascular Outlook: Pharmaceutical, Medical Device, New Technologies - Past, Present, and Future 10/1/2009 \| published by: PharmaLive Special Reports ... market-leading brands in five primary cardiovascular segments with statistical data and analytical reviews of revenue and investment activity by brand and device. Readers will get an understanding of future growth drivers that will affect specific ... \| more...	$535.00
Top 20 Japanese Companies & Their Pipelines 2009 10/1/2009 \| published by: PharmaLive Special Reports ... In addition to expansion through acquisition strategies, Japanese pharmaceutical manufacturers may realize opportunities closer to home, as the Asia-Pacific region is a major emerging market for the development of orphan drugs. Many leading Asian countries ... \| more...	$225.00
Top 50 Specialty Pharmaceutical Companies 10/1/2009 \| published by: PharmaLive Special Reports ... off patent, including Pfizer's Lipitor, GlaxoSmithKline's Advair, and Sanofi-Aventis' and Bristol-Myers Squibb's Plavix. Also contributing to the generic sector's growth will be increased demand for lower-priced medicines from emerging regions including Asia, Eastern Europe, and ... \| more...	$275.00
Top 20 Pipelines 2009 12/1/2009 \| published by: PharmaLive Special Reports ... M&A strategies, focused on acquiring companies with a more robust portfolio of compounds in development. Others have addressed pipeline challenges internally by re-aligning R&D initiatives to focus on developing medicines within specific disease classes and ... \| more...	$495.00
Mergers & Acquisitions, Partnerships, & Collaborations 2010 - Review and Outlook 1/1/2010 \| published by: PharmaLive Special Reports ... the mergers of Merck/Schering-Plough Corp. and Roche/Genentech. These combinations have bolstered each organizations' product portfolio and established a footprint in market segments previously not included in their business strategy - most notably in biotechnology. While ... \| more...	$445.00
US Appliance Industry 2010: Market Share, Life Expectancy & Replacement Market, and Saturation Levels 1/1/2010 \| published by: PharmaLive Special Reports ... older, less-efficient models with those that offer energy cost savings and tax incentives. However, while consumer confidence remains unsteady, unessential small appliance sales may suffer. Whirlpool continues its dominance of the U.S. major appliance market, ... \| more...	$275.00
58th Annual Appliance Industry: Overview and Forecast 2/1/2010 \| published by: PharmaLive Special Reports ... energy-efficient units have stimulated recovery in the appliance sector. Manufacturers are placing greater emphasis on developing products that meet the U.S. government's criteria for ENERGY STAR© certification. Consumer demand for these energy-efficient units will only ... \| more...	$245.00

< prev 1 2 3 4 5 next >